title: [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain].
abstract: Results of the therapy of patients with toxicohypoxic encephalopathy diagnosis upon heavy poisoning by psychotropic substances are presented. It is established that administration of the antihypoxant cytoflavin provides for a substantial decrease in the extent of metabolic disorders related to the development of heavy hypoxia. The use of cytoflavin significantly decreases the degree of encephalopathy and favors faster and better recovery of the mnestic and other cognitive functions in patients upon heavy toxicohypoxic brain damage caused by acute poisoning.
authors.forename: Kh V
authors.initials: KhV
authors.lastname: Batotsyrenova
authors.forename: G A
authors.initials: GA
authors.lastname: Livanov
authors.forename: G V
authors.initials: GV
authors.lastname: Shestova
authors.forename: K V
authors.initials: KV
authors.lastname: Sizova
authors.forename: V D
authors.initials: VD
authors.lastname: Velikova
mesh_terms: D000328:Adult; D001930:Brain Injuries / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D003072:Cognition Disorders / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D004338:Drug Combinations; D005260:Female; D005486:Flavin Mononucleotide / Q000008:administration & dosage*; D006801:Humans; D002534:Hypoxia, Brain / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007290:Inosine Diphosphate / Q000008:administration & dosage*; D008297:Male; D009536:Niacinamide / Q000008:administration & dosage*; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000009:adverse effects; D013386:Succinates / Q000008:administration & dosage*
chemical_list: D004338:Drug Combinations; D011619:Psychotropic Drugs; D013386:Succinates; C507879:cytoflavin; D009536:Niacinamide; D005486:Flavin Mononucleotide; D007290:Inosine Diphosphate